Related Experiment Video
Updated: Jul 15, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Recommendations for the management of migraine in paediatric patients
Umberto Balottin1, Cristiano Termine
1Child Neuropsychiatry Unit, Department of Clinical and Biological Sciences, University of Insubria and Macchi Foundation Hospital, Varese, p.zza Biroldi, 19, 21100 Varese, Italy. umberto.balottin@uninsubria.it
Insights
Pediatric migraine management requires personalized strategies. Non-pharmacological approaches like lifestyle changes and behavioral therapy may be more effective than medication for migraine prevention in children and adolescents.
Area of Science:
- Pediatric Neurology
- Child Psychiatry
- Clinical Pharmacology
Background:
- Migraine is a prevalent and debilitating neurological disorder in children and adolescents.
- Its pathogenesis involves complex interactions between biological, psychological, and environmental factors.
- Effective management necessitates tailored strategies considering both pharmacological and non-pharmacological interventions.
Purpose of the Study:
- To review current evidence on the pharmacological and non-pharmacological management of migraine in pediatric populations.
- To provide guidance on the appropriate use of acute and prophylactic treatments.
- To emphasize the importance of a holistic, individualized approach to pediatric migraine care.
Main Methods:
- Systematic review of existing literature on pediatric migraine treatment.
- Analysis of efficacy and safety data for various acute and prophylactic medications.
- Evaluation of non-pharmacological interventions and their role in management.
Main Results:
- Ibuprofen and acetaminophen are recommended for symptomatic relief in children and adolescents.
- Sumatriptan nasal spray may be effective for adolescents.
- Flunarizine shows potential for prophylaxis, while pizotifen and clonidine appear ineffective; data for other agents are conflicting or insufficient.
- Non-pharmacological interventions are suggested as potentially more effective than pharmacotherapy for migraine prophylaxis.
Conclusions:
- Individualized treatment plans are crucial for managing pediatric migraine, considering developmental aspects and comorbidities.
- Non-pharmacological strategies, including trigger avoidance, lifestyle regulation, and psychological therapies, are highly recommended for prophylaxis.
- Pharmacological options should be carefully selected based on age, symptoms, and available evidence.
Abstract:
Migraine is a common and disabling condition in children and adolescents. The complexity of migraine on a pathogenetic and clinical level results from the interaction between biological, psychological and environmental factors. Appropriate management requires an individually tailored strategy giving due consideration to both pharmacological and non-pharmacological measures. Ibuprofen (7.5-10.0 mg/kg) and acetaminophen (15 mg/kg) are safe and effective, and should be considered for symptomatic treatment. Sumatriptan nasal spray (5 and 20 mg) is also likely to be effective, but at the moment, should be considered for the treatment of adolescents only. With reference to prophylactic drug treatment, the available data suggest that flunarizine (5 mg/day) is likely to be effective and pizotifen and clonidine are likely to be ineffective. The efficacy data regarding propranolol, nimodipine and trazodone are conflicting. Insufficient evidence is available on cyproheptadine, amitriptyline, divalproex sodium, topiramate, levetiracetam, gabapentin or zonisamide. The management of migraine in children needs an individualised therapeutic approach, directed to the whole person of the child, taking into account the developmental perspective and the high rate of psychiatric comorbidities. It is the authors' opinion that for the prophylaxis of migraine, interventions such as identification and avoidance of trigger factors, regulation of lifestyle, relaxation, biofeedback, cognitive behavioural treatment and psychological or psychotherapeutic interventions (e.g., psychodynamics) could be much more effective than pharmacotherapy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Tonsillitis II: Management
